Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus).
The selection of maximum concentrations for in vitro mammalian cell genotoxicity assays was reviewed at the 5th International Workshop on Genotoxicity Testing (IWGT), 2009. Currently, the top concentration recommended when toxicity is not limiting is 10mM or 5mg/ml, whichever is lower. The discussion was whether to reduce the limit, and if so whether the 1mM limit proposed for human pharmaceuticals was appropriate for testing other chemicals. The consensus was that there was reason to consider reducing the 10mM limit, and many, but not all, attendees favored a reduction to 1mM. Several proposals are described here for the concentration limit. The in vitro cytogenetics expert working group also discussed appropriate measures and level of cytotoxicity. Data were reviewed from a multi-laboratory trial of the in vitro micronucleus (MN) assay with multiple cell types and several types of toxicity measurements. The group agreed on a preference for toxicity measures that take cell proliferation after the beginning of treatment into account (relative increase in cell counts, relative population doubling, cytokinesis block proliferation index or replicative index), and that this applies both to in vitro MN assays and to in vitro chromosome aberration assays. Since relative cell counts (RCC) underestimate toxicity, many group members favored making a recommendation against the use of RCC as a toxicity measure for concentration selection. All 14 chemicals assayed for MN induction in the multi-laboratory trial were detected without exceeding 50% toxicity by any measure, but some were positive only at concentrations with toxicity quite close to 50%. The expert working group agreed to accept the cytotoxicity range recommended by OECD guideline 487 (55±5% toxicity at the top concentration scored). This also reinforces the original intent of the guidance for the in vitro chromosome aberration assay, where ">50%" was intended to target the range close to 50% toxicity.
Merck Research Laboratories, W 45-316, West Point, PA 19486, USA. sheila_galloway@merck.com
Sheila
S
Galloway
Elisabeth
E
Lorge
Marilyn J
MJ
Aardema
David
D
Eastmond
Mick
M
Fellows
Robert
R
Heflich
David
D
Kirkland
Dan D
DD
Levy
Anthony M
AM
Lynch
Daniel
D
Marzin
Takeshi
T
Morita
Maik
M
Schuler
Günter
G
Speit
D000818:Animals; D002869:Chromosome Aberrations; D017408:Guidelines as Topic; D006801:Humans; D008322:Mammals; D015162:Micronucleus Tests / Q000592:standards*; D009152:Mutagenicity Tests / Q000592:standards*; D009153:Mutagens / Q000008:administration & dosage
D009153:Mutagens